These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9331949)
1. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Pichuantes S; Vera S; Bourdeau A; Pece N; Kumar S; Wayner EA; Letarte M Tissue Antigens; 1997 Sep; 50(3):265-76. PubMed ID: 9331949 [TBL] [Abstract][Full Text] [Related]
2. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Gougos A; St Jacques S; Greaves A; O'Connell PJ; d'Apice AJ; Bühring HJ; Bernabeu C; van Mourik JA; Letarte M Int Immunol; 1992 Jan; 4(1):83-92. PubMed ID: 1371694 [TBL] [Abstract][Full Text] [Related]
3. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572 [TBL] [Abstract][Full Text] [Related]
4. Expression of normal and truncated forms of human endoglin. Raab U; Velasco B; Lastres P; Letamendía A; Calés C; Langa C; Tapia E; López-Bote JP; Páez E; Bernabéu C Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):579-88. PubMed ID: 10215596 [TBL] [Abstract][Full Text] [Related]
5. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Paquet ME; Pece-Barbara N; Vera S; Cymerman U; Karabegovic A; Shovlin C; Letarte M Hum Mol Genet; 2001 Jun; 10(13):1347-57. PubMed ID: 11440987 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Takahashi N; Haba A; Matsuno F; Seon BK Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802 [TBL] [Abstract][Full Text] [Related]
7. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105). Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902 [TBL] [Abstract][Full Text] [Related]
8. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. Rokhlin OW; Cohen MB; Kubagawa H; Letarte M; Cooper MD J Immunol; 1995 May; 154(9):4456-65. PubMed ID: 7722302 [TBL] [Abstract][Full Text] [Related]
10. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Matsuno F; Haruta Y; Kondo M; Tsai H; Barcos M; Seon BK Clin Cancer Res; 1999 Feb; 5(2):371-82. PubMed ID: 10037187 [TBL] [Abstract][Full Text] [Related]
12. Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. Guerrero-Esteo M; Lastres P; Letamendía A; Pérez-Alvarez MJ; Langa C; López LA; Fabra A; García-Pardo A; Vera S; Letarte M; Bernabéu C Eur J Cell Biol; 1999 Sep; 78(9):614-23. PubMed ID: 10535303 [TBL] [Abstract][Full Text] [Related]
13. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells. She X; Matsuno F; Harada N; Tsai H; Seon BK Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611 [TBL] [Abstract][Full Text] [Related]
14. Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms. Lux A; Gallione CJ; Marchuk DA Hum Mol Genet; 2000 Mar; 9(5):745-55. PubMed ID: 10749981 [TBL] [Abstract][Full Text] [Related]
15. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. Gougos A; Letarte M J Biol Chem; 1990 May; 265(15):8361-4. PubMed ID: 1692830 [TBL] [Abstract][Full Text] [Related]
16. The use of recombinant vaccinia virus to generate monoclonal antibodies against the cell-surface glycoprotein endoglin. Luque A; Cabañas C; Raab U; Letamendia A; Páez E; Herreros L; Sánchez-Madrid F; Bernabeu C FEBS Lett; 1997 Aug; 413(2):265-8. PubMed ID: 9280294 [TBL] [Abstract][Full Text] [Related]
17. [PRODUCTION AND CHARACTERIZATION OF THE PANEL OF MONOCLONAL ANTIBODIES AGAINST HUMAN ENDOGLIN]. Smirnov IV; Gryazeva IV; Samoilovich MP; Terekhina LA; Pinevich AA; Krylova AA; Krutetskaia IY; Nikolsky NN; Klimovich VB Tsitologiia; 2015; 57(7):499-508. PubMed ID: 26591062 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies. Tabata M; Kondo M; Haruta Y; Seon BK Int J Cancer; 1999 Aug; 82(5):737-42. PubMed ID: 10417773 [TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand. Ge AZ; Butcher EC Gene; 1994 Jan; 138(1-2):201-6. PubMed ID: 8125301 [TBL] [Abstract][Full Text] [Related]
20. Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. Llorca O; Trujillo A; Blanco FJ; Bernabeu C J Mol Biol; 2007 Jan; 365(3):694-705. PubMed ID: 17081563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]